Research-use-only assay identifies 28 urinary targets and 25 antibiotic resistance markers with same-day turnaround time.
Molecular Designs has launched the Urogenital Microbiota with ABX 53 Simplicity Panel, a multiplex PCR-based research assay designed to detect urinary pathogens and antibiotic resistance genes in a single test.
The panel identifies 28 urinary targets—20 bacterial, 7 fungal, and one protozoan—along with 25 antibiotic resistance markers, delivering same-day results through a streamlined workflow. The assay is available in ready-to-use 96-well and 384-well formats, with breakaway panels available in the 96-well configuration to minimize waste.
“With drug resistance on the rise, labs are being asked to do more with fewer resources,” says Michael Clark, CEO of Molecular Designs, in a release. “This panel was built to help them keep pace by providing answers with a workflow that fits seamlessly into today’s research lab environment.”
Addressing Antimicrobial Resistance Challenges
The launch comes as antimicrobial resistance continues to present significant challenges for clinical laboratories worldwide. By combining pathogen detection with resistance gene profiling in a single assay, the panel aims to provide researchers with tools to track emerging resistance mechanisms and microbial profiles across urogenital samples.
“Antimicrobial resistance isn’t just a lab challenge, it’s one of the most pressing threats in medicine today,” says Dr Greer Massey, chief scientific officer at Molecular Designs, in a release. “By combining urogenital target detection with resistance gene profiling in a single panel, this product gives researchers the insight they need to track emerging threats and make more informed decisions, faster.”
The Birmingham, Alabama-based company manufactures its multiplex PCR-based panels under GMP and ISO 13485:2016 quality standards. All products are designated for research use only and are not intended for diagnostic procedures.
Molecular Designs was founded by physicians seeking to increase accessibility to molecular testing technologies. The company offers various multiplex PCR-based panels along with complementary reagents and instrumentation for research applications.
ID 10474132 © Alexander Raths | Dreamstime.com
